loading page

Tranexamic acid in COVID-19 pneumonia
  • Hayder Al-kuraishy,
  • Ali Al-Gareeb,
  • Gaber Batiha
Hayder Al-kuraishy
Mustansiriyah University
Author Profile
Ali Al-Gareeb
Mustansiriyah University
Author Profile
Gaber Batiha
Damanhour University
Author Profile

Abstract

Since the beginning of the current coronavirus 2019 (COVID-19) outbreak, an intense number of studies have been done in an attempt to discover effective therapies, not only from the point of view of discovering new drugs, but also from its repurposing. Recent studies have proposed tranexamic acid (TXA), a hemostatic drug widely used in clinical practice, as a potential therapeutic option for COVID-19 as it reduces plasmin levels. Thus, this letter to the editor aims to provide a critical overview on the use of TXA in the treatment of the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection.